REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 3rd, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledApril 3rd, 2019 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of March 28, 2019, between ReShape Lifesciences Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 3rd, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledApril 3rd, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2019, between ReShape Lifesciences Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURED SUBORDINATED ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE DUE JUNE 28, 2019Convertible Security Agreement • April 3rd, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledApril 3rd, 2019 Company Industry JurisdictionTHIS SECURED SUBORDINATED ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Secured Subordinated Original Issue Discount Convertible Debentures of ReShape Lifesciences Inc., a Delaware corporation (the “Company”), having its principal place of business at 1001 Calle Amanecer, San Clemente, CA 92673, designated as its Secured Subordinated Original Issue Discount Convertible Debenture due June 28, 2019 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
SECURITY AGREEMENTSecurity Agreement • April 3rd, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledApril 3rd, 2019 Company Industry JurisdictionThis SECURITY AGREEMENT, dated as of March 28, 2019 (this “Agreement”), is among ReShape Lifesciences Inc., a Delaware corporation (the “Company”), all of the Subsidiaries of the Company (such subsidiaries, the “Guarantors” and together with the Company, the “Debtors”) and the holders of the Company’s Secured Subordinated Original Issue Discount Convertible Debentures due three months following their issuance, in the original aggregate principal amount of $2,200,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).